HIV & AIDS

Researchers hunt for drugs that keep HIV latent

When the human immunodeficiency virus infects cells, it can either exploit the cells to start making more copies of itself or remain dormant—a phenomenon called latency. Keeping these reservoirs latent is a challenge. A ...

Neuroscience

Team develops first of a kind in-vitro 3-D neural tissue model

Researchers at the University of Illinois at Urbana-Champaign have successfully used stem cells to engineer living biohybrid nerve tissue to develop 3-D models of neural networks with the hopes of gaining a better understanding ...

Medical research

Turbo chip for drug development

In spite of increasing demand, the number of newly developed drugs decreased continuously in the past decades. The search for new active substances, their production, characterization, and screening for biological effectiveness ...

Oncology & Cancer

Tumor-like spheres help scientists discover smarter cancer drugs

May 14, 2018—Cancer is a disease often driven by mutations in genes. As researchers learn more about these genes, and the proteins they code for, they are seeking smarter drugs to target them. The ultimate goal is to find ...

page 2 from 13